Momenta Pharmaceuticals Inc (NASDAQ:MNTA)

21.45
Delayed Data
As of Jun 21
 -0.85 / -3.81%
Today’s Change
11.85
Today|||52-Week Range
24.90
+53.76%
Year-to-Date
No recent news for Momenta Pharmaceuticals Inc.

Today’s Trading

Previous close22.30
Today’s open22.20
Day’s range21.40 - 22.25
Volume355,080
Average volume (3 months)724,050
Market cap$1.6B
Data as of 4:00pm ET, 06/21/2018

Growth & Valuation

Earnings growth (last year)-287.10%
Earnings growth (this year)-23.77%
Earnings growth (next 5 years)--
Revenue growth (last year)+26.70%
P/E ratioNM
Price/Sales7.35
Price/Book4.30

Competitors

 Today’s
change
Today’s
% change
XLRNAcceleron Pharma Inc-0.42-1.12%
SGMOSangamo Therapeutics...-1.93-10.66%
----
EPZMEpizyme Inc-0.90-5.66%
Data as of 4:00pm ET, 06/21/2018

Financials

Next reporting dateAugust 2, 2018
EPS forecast (this quarter)-$0.36
Annual revenue (last year)$138.9M
Annual profit (last year)-$88.1M
Net profit margin-63.43%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Craig A. Wheeler
Chief Operating Officer &
Chief Scientific Officer
Ganesh Venkataraman Kaundinya
Corporate headquarters
Cambridge, Massachusetts

Forecasts